Report Library
View More
Datamonitor Healthcare Oncology Dis...
June 28, 2022
Datamonitor Healthcare Oncology Dis...
June 24, 2022
Datamonitor Healthcare CV&Met Disea...
June 24, 2022
Datamonitor Healthcare Oncology Dis...
June 22, 2022
Datamonitor Healthcare Oncology Dis...
June 20, 2022
Datamonitor Healthcare CNS Disease ...
June 16, 2022
Datamonitor Healthcare Respiratory ...
June 15, 2022
Datamonitor Healthcare Oncology Dis...
June 13, 2022
Datamonitor Healthcare CV&Met Disea...
June 7, 2022
Datamonitor Healthcare CV&Met Disea...
June 3, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/22/22 | Galderma | Nemolizumab for Pruritus | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/22 | CymaBay Therapeutics (CBAY) | Seladelpar for Primary Biliary Cholangitis (PBC) and Hepatic Fibrosis | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/21/22 | Ionis Pharmaceuticals (IONS) | Eplontersen for Hereditary Transthyretin (hATTR) Amyloidosis With Polyneuropathy (Familial Amyloid Polyneuropathy) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/21/22 | Merck (MRK) | V116 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/17/22 | ACADIA Pharmaceuticals (ACAD) | Nuplazid for Dementia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 12/31/02 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation (Emerging Markets) |
| 06/25/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/25/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/25/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 06/25/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
